Depreciation of BeOne Medicines Ltd. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BeOne Medicines Ltd. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • BeOne Medicines Ltd. Depreciation for the quarter ending 31 Dec 2025 was $34,417,000, a 30% decline year-over-year.
  • BeOne Medicines Ltd. Depreciation for the twelve months ending 31 Dec 2025 was $131,615,000, a 21% decline year-over-year.
  • BeOne Medicines Ltd. annual Depreciation for 2025 was $131,615,000, a 21% decline from 2024.
  • BeOne Medicines Ltd. annual Depreciation for 2024 was $166,938,000, a 108% increase from 2023.
  • BeOne Medicines Ltd. annual Depreciation for 2023 was $80,436,000, a 29% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

BeOne Medicines Ltd. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $131,615,000 $34,417,000 -$14,629,000 -30% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $146,244,000 $35,730,000 -$34,298,000 -49% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $180,542,000 $29,854,000 +$6,100,000 +26% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $174,442,000 $31,614,000 +$7,504,000 +31% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $166,938,000 $49,046,000 +$28,184,000 +135% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $138,754,000 $70,028,000 +$50,786,000 +264% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $87,968,000 $23,754,000 +$2,447,000 +11% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $85,521,000 $24,110,000 +$5,085,000 +27% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $80,436,000 $20,862,000 +$3,815,000 +22% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $76,621,000 $19,242,000 +$4,028,000 +26% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $72,593,000 $21,307,000 +$6,846,000 +47% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $65,747,000 $19,025,000 +$3,445,000 +22% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $62,302,000 $17,047,000 +$4,745,000 +39% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $57,557,000 $15,214,000 +$3,441,000 +29% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $54,116,000 $14,461,000 +$3,238,000 +29% 01 Apr 2022 30 Jun 2022 10-Q 02 Aug 2023 2023 Q2
Q1 2022 $50,878,000 $15,580,000 +$6,136,000 +65% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $44,742,000 $12,302,000 +$4,662,000 +61% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $40,080,000 $11,773,000 +$3,616,000 +44% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $36,464,000 $11,223,000 +$3,544,000 +46% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $32,920,000 $9,444,000 +$1,977,000 +26% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $30,943,000 $7,640,000 +$488,000 +6.8% 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $30,455,000 $8,157,000 +$4,466,000 +121% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $25,989,000 $7,679,000 +$4,316,000 +128% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $21,673,000 $7,467,000 +$4,382,000 +142% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $17,291,000 $7,152,000 +$4,442,000 +164% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $12,849,000 $3,691,000 +$1,484,000 +67% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2020 Q3
Q2 2019 $11,365,000 $3,363,000 +$1,264,000 +60% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $10,101,000 $3,085,000 +$1,101,000 +55% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $9,000,000 $2,710,000 +$1,011,000 +60% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $7,989,000 $2,207,000 +$970,000 +78% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $7,019,000 $2,099,000 +$1,559,000 +289% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $5,460,000 $1,984,000 +$1,120,000 +130% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $4,340,000 $1,699,000 +$1,226,000 +259% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $3,114,000 $1,237,000 +$732,000 +145% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $2,382,000 $540,000 +$48,000 +9.8% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $2,334,000 $864,000 +$425,000 +97% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $1,909,000 $473,000 +$55,000 +13% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $1,854,000 $505,000 +$103,000 +26% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $1,751,000 $492,000 +$119,000 +32% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $1,632,000 $439,000 +$87,000 +25% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $1,545,000 $418,000 01 Oct 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $402,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $373,000 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2
Q1 2015 $352,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

BeOne Medicines Ltd. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $131,615,000 -$35,323,000 -21% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $166,938,000 +$86,502,000 +108% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $80,436,000 +$18,134,000 +29% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $62,302,000 +$17,560,000 +39% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $44,742,000 +$13,799,000 +45% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $30,943,000 +$13,652,000 +79% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $17,291,000 +$8,291,000 +92% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $9,000,000 +$4,660,000 +107% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $4,340,000 +$2,431,000 +127% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $1,909,000 +$364,000 +24% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $1,545,000 -$12,000 -0.77% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $1,557,000 01 Jan 2014 31 Dec 2014 10-K 22 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.